Nutriterra® Total Omega-3, a novel canola-based omega-3 oil, has received Health Canada approval as an ingredient in dietary supplements. This approval, granted by Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD), includes a Natural Product Number (NPN 80136254) and authorizes its use with the following health claims:
- Supports heart health and cardiovascular function
- Supports normal brain function
- Source of DHA and ALA for maintaining good health
- Source of omega-3 fatty acids for the maintenance of good health
Benita Boettner, General Manager of Nufarm Nutritional, noted that this milestone reinforces Nutriterra’s role in supporting heart and brain health, offering a sustainable plant-based alternative to traditional omega-3 sources like fish oil.
Human clinical trials have demonstrated Nutriterra’s efficacy, with a 2000 mg/day serving significantly improving key indicators of omega-3 status, such as the OmegaScore™ and the Omega-3 Index. These findings, published in Frontiers in Nutrition, confirm Nutriterra’s ability to support cardiovascular and brain health.
Nutriterra bridges the gap between the demand for essential omega-3 nutrients and the ocean’s limited capacity to provide them sustainably. One hectare of Nuseed Omega-3 Canola can produce as much DHA as 10,000 kg of wild-caught fish.
This approval follows similar recognition from global regulatory bodies, including the FDA’s New Dietary Ingredient status in 2021, and positions Nutriterra as a leader in the plant-based omega-3 space.
